… ’ ADAS-Cog scores and serum plasmalogen levels. For the 40 included AD patients with
an ADAS-Cog score between 20 and 46, we retested their ADAS-Cog score 1 year later. The …

… treatment and placebo groups in the primary and secondary outcomes of cognitive function.
The MMSE-J score showed a nearly significant improvement in the treatment group while no …

… Safety, tolerability and therapeutic effects on cognition and mobility were also evaluated.
DHA plasmalogen levels … Scores range from 0 to 30 with higher scores representing greater …

… We evaluated sum up scores in 7 … plasmalogen. The objective of this study was to verify
whether the supplement containing plasmalogen affects the memory skill and the cognitive …

… between CSF t-tau and of the CSF t-tau/Aβ 1-42 ratio with PL-PX and PBV, ie, the same
indices associated with the AD versus CN and LMCI versus CN and with the cognitive scores (…

… and brain plasmalogens with higher levels of AD pathology and lower cognition scores and
… Furthermore, it has been recently reported that high blood plasmalogen levels neutralize …

… The primary endpoint was change in the MMSE-J score. Its total score ranges from 0 to
30 and a lower score indicates poorer cognitive function. The secondary endpoints were …

… on cognition and the prevalence of dementia is dependent upon the plasmalogen status of
the … Composite score and scores representing each cognitive domain were used for statistical …

… There were no correlations between RME or WME scores and levels of other PlsEtn species
… is rich in PlsEtn, improved cognitive impairment and altered levels of PlsEtn species in Aβ-…

… of composite indices comprising of various ratios of PlsEtn and PtdEtn species bearing
polyunsaturated fatty acids at sn-2 position (DHA, adrenic acid, and EPA) with cognitive scores …